X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Breast Cancer

期刊標題檢索 BREAST CANCER-T 最新評論: Hello, I just submitted my paper. May I ask if you have any updates? ... (2024-09-26)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Breast Cancer]您好,您是該頁面的第 38095 位訪客。

期刊簡介
期刊名稱Breast Cancer Breast Cancer
LetPub Score
5.2
50 ratings
Rate

Reputation
6.4

Influence
3.9

Speed
7.0

期刊簡稱BREAST CANCER-TOKYO
ISSN1340-6868
E-ISSN1880-4233
h-index47
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.701.0541.049
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Radiology, Nuclear Medicine and Imaging
Q156 / 333
Category: Medicine
Subcategory: Pharmacology (medical)
Q160 / 272
Category: Medicine
Subcategory: Oncology
Q2105 / 404

自引率 (2023-2024)2.50%自引率趨勢
掲載範囲
Breast Cancer, the official journal of the Japanese Breast Cancer Society, publishes articles that contribute to progress in the field, in basic or translational research and also in clinical research, seeking to develop a new focus and new perspectives for all who are concerned with breast cancer. The journal welcomes all original articles describing clinical and epidemiological studies and laboratory investigations regarding breast cancer and related diseases. The journal will consider five types of articles: editorials, review articles, original articles, case reports, and rapid communications. Although editorials and review articles will principally be solicited by the editors, they can also be submitted for peer review, as in the case of original articles. The journal provides the best of up-to-date information on breast cancer, presenting readers with high-impact, original work focusing on pivotal issues.
官方網站https://www.springer.com/12282
在線稿件提交https://www.editorialmanager.com/brca
開放訪問No
出版商Springer Japan
主題領域ONCOLOGY
出版國/地區JAPAN
發行頻率年6回刊行
創刊年1994
每年文章數97每年文章數趨勢
黃金OA百分比34.31%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
OBSTETRICS & GYNECOLOGYSCIEQ114/136
ONCOLOGYSCIEQ295/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1340-6868%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【Breast Cancer】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Women and BirthH-index: 31

    CiteScore: 7.20
    Journal of Gynecologic OncologyH-index: 30

    CiteScore: 6.00
    學科內最受檢索的期刊 頁面查看次數
    Journal of Gynecologic Oncology27639
    Women and Birth16669
  •  

    Breast Cancer Breast Cancer
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Breast Cancer] 的評論撰寫評論
作者: hiko


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-26 11:50:21 評論於
Hello, I just submitted my paper. May I ask if you have any updates? How long is the average peer review process? How long does it usually take to be sent for external review? Can I find this information on its home page? Is it user-friendly for Chinese scholars? Looking forward to your reply. Thank you.
(0) 讚! | hiko

作者: 发论文毕业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-22 22:39:40 評論於
Hello, can submissions be in Word format or only in LaTeX format?
(0) 讚! | 发论文毕业

作者: brca


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-03 10:25:33 評論於
5.1 Submission
6.3 Major Revision
6.14 Revision
6.21 Required Reviews Completed
(0) 讚! | brca

作者: 奉天芊丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-07 10:37:07 評論於
My manuscript has also been under review for 3 months. The reviewers provided major revisions suggestions, with one reviewer finding them acceptable, while the other reviewer provided a lot of comments. Some of the key treatment information mentioned in the comments cannot be completed yet, but I personally feel that not providing this information will not significantly impact the analysis results. Can I still salvage the manuscript? If so, how can I salvage it?
(0) 讚! | 奉天芊丽

作者: 独孤玉茂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-01 10:29:46 評論於
Springer's journals, you definitely won't find them in Elsevier
(0) 讚! | 独孤玉茂

作者: Bennett Freeman


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-25 18:16:05 評論於
Research focus: Breast cancer sharing experiences: Can't you find the external audit progress on the Elsevier public account?
(0) 讚! | Bennett Freeman

作者: 岭南醉梦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-17 20:16:19 評論於
Where are we?
(0) 讚! | 岭南醉梦

作者: 龟甲迎真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-18 21:03:18 評論於
The submission guidelines are listed on their homepage
(0) 讚! | 龟甲迎真

作者: 独孤玉茂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-26 16:38:57 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0 
Focused research direction: Breast cancer 
Experience sharing: The review process was fast, but it took nearly 2 months under review with two reviewers who provided detailed feedback that was not difficult to address. After revisions, the paper was accepted within half a month. The whole process took 3 months
(0) 讚! | 独孤玉茂

作者: 璃月建修


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-18 15:14:11 評論於
Can you please translate the following passage into English and Japanese, with the titles ":" and ":"
(0) 讚! | 璃月建修

作者: Troy Helina


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-13 08:34:55 評論於
How do we resolve this in the future?
(0) 讚! | Troy Helina

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 19:15:22 評論於
Please translate the following paragraph into English and Japanese, with titles ":" and ":"
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 11:44:53 評論於
The keywords of a SCI paper are generally 3 to 8
(0) 讚! | 维尔娜菲茨杰拉德

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 23:50:23 評論於
How many keywords are typically required for a regular journal submission?
(0) 讚! | 龙鳞孝礼

作者: 破戒阳平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 09:50:49 評論於
How many keywords is the minimum?
(0) 讚! | 破戒阳平

作者: 雅健来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-20 12:52:34 評論於
+1, Have you found it?
(0) 讚! | 雅健来了

作者: 东风夜卉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-08-06 08:08:00 評論於
Still looking, have you found it?
(0) 讚! | 东风夜卉

作者: 森丽baby


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-04-27 08:49:10 評論於
Hello, may I ask if you need to upload the original data for breast cancer?
(0) 讚! | 森丽baby

作者: Primo Addison


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-02-25 19:29:24 評論於
Revised three times, it took nine months to submit the manuscript. If you are in a rush to graduate, then please don't submit it
(0) 讚! | Primo Addison

作者: 清雅少爷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-03-26 12:43:00 評論於
I also want to submit my work. Do you have the link?
(0) 讚! | 清雅少爷

作者: 四象永宁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-10-20 08:07:59 評論於
Review Speed: 1.0 | Submission Acceptance Rate: 5.0
Experience Sharing: The reasons for manuscript handling are extremely perfunctory
(0) 讚! | 四象永宁

作者: 水桥含芙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-12-28 18:37:09 評論於
I am preparing to submit to breast cancer, and during the submission process, I found out that I need to submit a Certification Form and Conflict of Interest Disclosure Form (All authors). I couldn't find the Certification Form, so I urgently need a download link, and could you please guide me on how to fill out these forms? Thank you so much!!!
(0) 讚! | 水桥含芙

作者: 努力啊大得深


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-10-08 21:17:31 評論於
Review speed: 2.0 | Submission hit rate: 50.0
Sharing of experience: Journal editors are responsible and the review speed is acceptable
(0) 讚! | 努力啊大得深

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Breast Cancer] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*